Cancer Biotherapy and Radiopharmaceuticals This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Long Noncoding RNA GUSBP11 Knockdown Alleviates Nasopharyngeal Carcinoma via Regulating miR-1226-3p/TM9SF4 Axis
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - June 8, 2022 Category: Cancer & Oncology Authors: Xiaofeng Zhang Jinzhi Liu MengMeng Ji GuiQin Qi Renling Qiao Source Type: research

Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein- α Recombinant Antibodies
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 24, 2022 Category: Cancer & Oncology Authors: Jianfeng Xu Shenghua Li Shasha Xu Juan Dai Zhigang Luo Jingjing Cui Fei Cai Changran Geng Zheng Wang Xiaobin Tang Source Type: research

Estimation of Cumulative Activity of 177Lu-Cetuximab from a Single Diagnostic 64Cu-Cetuximab Scan
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 20, 2022 Category: Cancer & Oncology Authors: Eric Laffon Roger Marthan Source Type: research

Environmentally Persistent Free Radical Promotes Lung Cancer Progression by Regulating the Expression Profile of miRNAs
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 17, 2022 Category: Cancer & Oncology Authors: Xiaomin Liu Binshu Chai Xianyi Wang Zong Wu Heng Zou Yangyang Liu Saijing Zheng Guangren Qian Zhongliang Ma Jie Lu Source Type: research

Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor Overexpression
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 16, 2022 Category: Cancer & Oncology Authors: Sreeja Raj Menon Arpit Mitra Avik Chakraborty Megha Tawate Sudeep Sahu Sutapa Rakshit Sujay Gaikwad Geetanjali Dhotre Archana Damle Sharmila Banerjee Source Type: research

miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 12, 2022 Category: Cancer & Oncology Authors: Jing Ma Sijia Na Panxi Wang Jinyi Li Shuyang He Fei Liu Source Type: research

Expression of Concern re: PHOX2B Is Associated with Neuroblastoma Cell Differentiation (doi: 10.1089/cbr.2015.1952)
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 4, Page 332-332, May 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 10, 2022 Category: Cancer & Oncology Source Type: research

Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase ABCB1 Expression
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 4, Page 233-245, May 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - May 10, 2022 Category: Cancer & Oncology Authors: Fei Gao Jianjun Han Yun Wang Lin Jia Wenjuan Luo Yan Zeng Source Type: research

Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - April 13, 2022 Category: Cancer & Oncology Authors: Amir R. Jalilian Arman Shahi Ian P. Swainson Hiroyuki Nakamura Meera Venkatesh Joao A. Osso Source Type: research

Retraction of: PHOX2B Is Associated with Neuroblastoma Cell Differentiation (doi: 10.1089/cbr.2015.1952)
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - April 11, 2022 Category: Cancer & Oncology Source Type: research

Synthesis, Radiolabeling, and Preclinical Evaluation of 68Ga/177Lu-Labeled Leuprolide Peptide Analog for the Detection of Breast Cancer
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 21, 2022 Category: Cancer & Oncology Authors: Subhani M. Okarvi Ibrahim Al-Jammaz Source Type: research

LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 2, Page 119-124, March 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 15, 2022 Category: Cancer & Oncology Authors: Zhe Zhang Li Nong Meng-Lei Chen Xiao-Li Gu Wei-Wei Zhao Ming-Hui Liu Wen-Wu Cheng Source Type: research

Circular RNA La-Related Protein 4 Inhibits Non-Small Cell Lung Cancer Cell Proliferation While Promotes Apoptosis Through Sponging microRNA-21-5p
Cancer Biotherapy and Radiopharmaceuticals,Volume 37, Issue 2, Page 111-118, March 2022. (Source: Cancer Biotherapy and Radiopharmaceuticals)
Source: Cancer Biotherapy and Radiopharmaceuticals - March 15, 2022 Category: Cancer & Oncology Authors: Zhen Yang Xiaoxiao Xu Cheng Song Source Type: research